• Explore /
  • Poster
  • / A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.

A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.

Abstract Poster

Authors

null

Sung Hee Lim

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea South

Sung Hee Lim , Jina Yun , Min-Young Lee , Han Jo Kim , Kyoung Ha Kim , Se Hyung Kim , Sang-Cheol Lee , Sang Byung Bae , Chan Kyu Kim , Namsu Lee , Kyu Taek Lee , Sung Kyu Park , Dae Sik Hong , Hyun Jong Choi , Jong Ho Moon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 344)

DOI

10.1200/JCO.2018.36.4_suppl.344

Abstract #

344

Poster Bd #

G5

Abstract Disclosures

Similar Posters

First Author: Masato Ozaka

First Author: Johanna Wilmink

First Author: Nai-Jung Chiang

First Author: Bhargavi Pulluri